PSA-based screening for localised prostate cancer. Uncertain benefits, potential adverse consequences, and many outstanding questions.
D003362:Cost-Benefit Analysis; D051517:Digital Rectal Examination; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000009:adverse effects*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood*; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity; D035501:Uncertainty
D017430:Prostate-Specific Antigen